- Home
- ROIV vs CTRA Comparison
ROIV vs CTRA Comparison
Compare ROIV & CTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ROIV | CTRA |
|---|---|---|
| Founded | 2014 | 1989 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.7B | 19.6B |
| IPO Year | 2021 | 1994 |
Fundamental Metrics
Financial Performance| Metric | ROIV | CTRA |
|---|---|---|
| Price | $28.12 | $34.36 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 15 |
| Target Price | $27.56 | ★ $35.27 |
| AVG Volume (30 Days) | 4.5M | ★ 10.2M |
| Earning Date | 02-06-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 2.55% |
| EPS Growth | N/A | ★ 49.33 |
| EPS | N/A | ★ 2.24 |
| Revenue | $29,053,000.00 | ★ $7,645,000,000.00 |
| Revenue This Year | N/A | $12.95 |
| Revenue Next Year | $594.84 | $7.21 |
| P/E Ratio | ★ N/A | $15.44 |
| Revenue Growth | N/A | ★ 40.07 |
| 52 Week Low | $8.73 | $22.33 |
| 52 Week High | $30.33 | $36.88 |
Technical Indicators
Market Signals| Indicator | ROIV | CTRA |
|---|---|---|
| Relative Strength Index (RSI) | 56.22 | 59.73 |
| Support Level | $26.94 | $23.03 |
| Resistance Level | $30.33 | N/A |
| Average True Range (ATR) | 0.95 | 1.10 |
| MACD | -0.12 | -0.05 |
| Stochastic Oscillator | 79.20 | 55.01 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About CTRA Coterra Energy Inc.
Coterra Energy Inc is an independent oil and gas company engaged in the development, exploration, and production of oil, natural gas, and natural gas liquids (NGLs). Its operations are mainly concentrated in areas with hydrocarbon resources, which are conducive to multi-well, repeatable development programs, and include the Permian Basin located in Texas and New Mexico, the Marcellus Shale in northeast Pennsylvania, and the Anadarko Basin located in the mid-continent region in Oklahoma. The company operates in one segment, oil and natural gas development, exploration, and production, in the continental U.S.